Just weeks after filing for FDA approval of its Galleri blood test for cancer screening, Grail has reported that a flagship trial of the technology in the UK failed to achieve its primary objective.

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in diagnoses at later stages of the disease. By Rebecca Robbins and Gina Kolata A ...

A blood test which looks for multiple types of cancer has failed to achieve its key objective in a major NHS trial, the company has announced. The Galleri blood test is being trialled on 142,000 NHS ...

Earnings over $24,480 (2026) before full retirement age reduces Social Security benefits. Claimed Social Security early; half of earnings above the threshold are withheld. Benefits recalculated at ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

Nick Blackmer is a librarian, fact-checker, and researcher with more than 20 years of experience in consumer-facing health and wellness content. The sitting-rising test measures how well you can sit ...

Last year, we brought you a story about the BhangmeterV2, an internet-of-things nuclear war monitor. With a cold-war-era ...

There are numerous email scams that land in your inbox every day, from malware-ridden attachments supposedly from a friend to IRS impersonators to fake calendar invitations. And what makes many of ...

If you immediately hit the Skip Ads, it's no longer considered, as YouTube calls it, an "engaged-view conversation," and the creator won't receive any of the ad money that would be owed to them if you ...